4300亿美元“灰飞烟灭”，全球“药王”，跌下神坛
"减重药" 相关文章
4300亿美元“灰飞烟灭”，全球“药王”，跌下神坛
国产GLP-1减重药玛仕度肽于美团开启首发预约。7月3日，刚刚获批的减重创新药物玛仕度肽注射液在美团医药健康旗下美团自营大药房首发上线，加上此前全网独家首发...
Mounjaro在印度熱銷，禮來搶佔減肥藥藍海，領先諾和諾德一步
减重药的这个生意能玩多久？
科学家发现流行减重药获益与风险共存
减重药司美格鲁肽和替尔泊肽均在中国上市，马斯克亲身试验给出建议
抢购合规司美“减肥神药”的人，“怀念”起了代购
司美格鲁肽“平替”赛道，挤满中国企业
美股异动 | 诺和诺德盘前跌超3% 荷兰对报销其减肥药物费用持谨慎态度
The Wall Street Journal: Bradley Olson shed 40 pounds on a weight-loss drug, then stopped taking it. He describes the challenges he faced the next fou...
The Wall Street Journal: Bradley Olson shed 40 pounds on a weight-loss drug, then stopped taking it. He describes the challenges he faced the next fou...
The Wall Street Journal: Bradley Olson shed 40 pounds on a weight-loss drug, then stopped taking it. He describes the challenges he faced the next fou...
The Wall Street Journal: Bradley Olson shed 40 pounds on a weight-loss drug, then stopped taking it. He describes the challenges he faced the next fou...
The Wall Street Journal: Bradley Olson shed 40 pounds on a weight-loss drug, then stopped taking it. He describes the challenges he faced the next fou...
